Compare RMI & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMI | BYSI |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.0M | 79.0M |
| IPO Year | N/A | 2017 |
| Metric | RMI | BYSI |
|---|---|---|
| Price | $14.78 | $2.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.4K | ★ 591.5K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 7.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.05 | $0.98 |
| 52 Week High | $17.37 | $3.44 |
| Indicator | RMI | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 54.46 | 55.99 |
| Support Level | $14.53 | $1.89 |
| Resistance Level | $14.75 | $2.16 |
| Average True Range (ATR) | 0.20 | 0.19 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 71.99 | 47.54 |
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.